Long-term survival of cancer patients compared to heart failure and stroke: a systematic review

BMC Cancer. 2010 Mar 22;10:105. doi: 10.1186/1471-2407-10-105.


Background: Cancer, heart failure and stroke are among the most common causes of death worldwide. Investigation of the prognostic impact of each disease is important, especially for a better understanding of competing risks. Aim of this study is to provide an overview of long term survival of cancer, heart failure and stroke patients based on the results of large population- and hospital-based studies.

Methods: Records for our study were identified by searches of Medline via Pubmed. We focused on observed and relative age- and sex-adjusted 5-year survival rates for cancer in general and for the four most common malignancies in developed countries, i.e. lung, breast, prostate and colorectal cancer, as well as for heart failure and stroke.

Results: Twenty studies were identified and included for analysis. Five-year observed survival was about 43% for all cancer entities, 40-68% for stroke and 26-52% for heart failure. Five-year age and sex adjusted relative survival was 50-57% for all cancer entities, about 50% for stroke and about 62% for heart failure. In regard to the four most common malignancies in developed countries 5-year relative survival was 12-18% for lung cancer, 73-89% for breast cancer, 50-99% for prostate cancer and about 43-63% for colorectal cancer. Trend analysis revealed a survival improvement over the last decades.

Conclusions: The results indicate that long term survival and prognosis of cancer is not necessarily worse than that of heart failure and stroke. However, a comparison of the prognostic impact of the different diseases is limited, corroborating the necessity for further systematic investigation of competing risks.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Aged
  • Cause of Death
  • Female
  • Heart Failure / mortality
  • Heart Failure / therapy*
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / mortality*
  • Neoplasms / pathology*
  • Risk
  • Stroke / mortality
  • Stroke / therapy*
  • Survival Rate
  • Treatment Outcome